Decoy Therapeutics Inc. (DCOY)
About Decoy Therapeutics Inc.
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2022
- $0
- Net income
- -$12.5M
- Total assets
- $11.1M
- Market cap
- $3.5M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.5M
- Shares outstanding
- 697.7K
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 29, 2015
Decoy Therapeutics Inc. (DCOY) Stock Price
- Reported a net loss of $12.5M in FY2022.
- Trading 66% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Decoy Therapeutics Inc..
Write a review
Decoy Therapeutics Inc.: frequently asked questions
Is Decoy Therapeutics Inc. an American company?
Decoy Therapeutics Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Decoy Therapeutics Inc. headquartered?
Decoy Therapeutics Inc. is headquartered in Houston, Texas, United States.
Is Decoy Therapeutics Inc. publicly traded?
Yes — Decoy Therapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol DCOY on the NASDAQ.
What does Decoy Therapeutics Inc. do?
Decoy Therapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
